The new Enterprise Solutions Hub will support the US, Canada and Latin America, offering services similar to its international counterpart in Warsaw, Poland
Moderna headquarters in Cambridge, Massachusetts, US. (Credit: Fletcher/Wikipedia)
US-based mRNA therapeutics and vaccines maker Moderna has unveiled plans to establish an Enterprise Solutions Hub in Atlanta, Georgia, US.
With the new enterprise solutions hub in Atlanta, the biotech company aims to provide services similar to its counterpart in Warsaw, Poland, established in May last year.
Its office in Atlanta will initially focus on delivering finance, human resources, procurement, and digital functions, said Moderna.
In addition, it will seek additional opportunities to offer functions and business services out of the hub, with the growth of the company’s operations.
The company is planning to hire around 150-200 full-time employees in Atlanta Hub in the coming two years, with plans to start operations in the second quarter this year.
Moderna CEO Stéphane Bancel said: “We are pleased to be expanding our footprint after a year of tremendous growth, which underscored the need for business services activities in proximity to skilled talent.
“Along with our centre in Poland, our Atlanta hub will bring us closer to realising our vision of building a company with centralised enterprise solutions hubs worldwide.
“As we build Moderna, we strive to use best business practices, and with Enterprise Hubs on different continents and digital investments, we can scale efficiently. We look forward to engaging with the diverse pool of talent in the Atlanta community.”
Moderna said it has considered key parameters, including access to workforce, sustainability, competitive landscape, risk, and business climate in selecting the location.
The company found the Atlanta site to be best-positioned to deliver its objectives for the Hub, with a skilled and diverse workforce, the business community and growth options.
The move follows Moderna’s recent plans to expand its footprint through establishing new commercial subsidiaries in 21 countries worldwide this year.